Safety and tolerability of Bifidobacterium longum subspecies infantis EVC001 supplementation in healthy term breastfed infants: A phase I clinical trial;Erratum: Safety and tolerability of Bifidobacterium longum subspecies infantis EVC001 supplementation in healthy term breastfed infants: A phase I clinical trial [BMC Pediatr., 17 (2017)(133)] DOI: 10.1186/s12887-017-0886-9

BMC Pediatrics

Volumn 17, Issue 1, 2017, Pages

  Smilowitz, Jennifer T ^a   Moya, Jackelyn ^a   Breck, Melissa A ^a   Cook, Chelsea ^a   Fineberg, Annette ^b   Angkustsiri, Kathleen ^c   Underwood, Mark A ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SUTTER HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d University of California at Davis School of Medicine   (United States)

Author keywords

Bifidobacterium longum subspecies infantis; Breast milk; Gut microbiome; Human milk oligosaccharides; Infant; Probiotics; Supplementation; Tolerability

Indexed keywords

ERRATUM; ERROR;

EID: 85027535022     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/s12887-017-0886-9     Document Type: Article

References (1)

1. Smilowitz J, et al. Safety and tolerability of Bifidobacterium longum subspecies infantis EVC001 supplementation in healthy term breastfed infants: a phase I clinical trial. BMC Pediatr. 2017;17:133. doi: 10.1186/s12887-017-0886-9.